CG87 · Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention. NICE technology appraisal guidance 182 (2009).
The incidence of STEMI has been declining over the past 20 years. It varies between regions and averages around 500 hospitalised episodes per million people each year in the UK. The London Ambulance Service attended 9657 cardiac arrests in 2011–12 for a population of around 8.2 million people (1177 per million
10 Jul 2013 Evidence-based recommendations on the acute management of myocardial infarction with ST-segment elevation (STEMI) in adults. follow-on primary PCI if indicated). 1.1.3 Deliver coronary reperfusion therapy (either primary PCI or fibrinolysis) as quickly as possible for eligible people with acute STEMI.
Chest pain of recent onset (2010) NICE guideline CG95. Unstable angina and NSTEMI (2010) NICE guideline CG94. Type 2 diabetes (2009) NICE guideline CG87. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention (2009) NICE technology appraisal guidance 182.
Everything NICE has said on the acute management of myocardial infarction with ST-segment elevation in an interactive flowchart.
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (review of technology appraisal guidance 182). This guidance was developed using the multiple treatment; or the person has diabetes (NICE technology appraisal intervention, NSTEMI or unstable angina (NICE technology.
Everything NICE has produced on the topic of acute coronary syndromes. Type 1 diabetes in adults Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti?platelet therapy (terminated appraisal) (TA351) July 2015

Annons

The photo has no tags

March 2018